Two Human Immunodeficiency Virus Vaccinal Lipopeptides Follow Different Cross-Presentation Pathways in Human Dendritic Cells

An efficient vaccine against human immunodeficiency virus (HIV) must induce good cellular immune responses. To do this, it must be processed and presented by dendritic cells, which are required for primary T-lymphocyte stimulation. We have previously shown that a model lipopeptide containing a short...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Virol
Autori principali:	Andrieu, Muriel, Desoutter, Jean-François, Loing, Estelle, Gaston, Jésintha, Hanau, Daniel, Guillet, Jean-Gérard, Hosmalin, Anne
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2003
Soggetti:	Virus-Cell Interactions
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140847/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12502869/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.2.1564-1570.2003
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!